Clinical Trials Browser

Phase 2 × Completed × Celecoxib × Clear all

NCT03084536 2024-12-24

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Phase 2 Completed

134 enrolled 9 charts

Breast Neoplasms

NCT02641314 2024-05-10

METRO-NB2012

Phase 2 Completed

Neuroblastoma

NCT00846430 2023-08-30

Medical Treatment of "High-Risk" Neurofibromas

Phase 2 Completed

9 enrolled 9 charts

Neurofibroma, Neurofibromatosis 1

NCT00538031 2023-04-21

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

52 enrolled 10 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00503035 2023-02-13

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Phase 2 Completed

51 enrolled 10 charts

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT03403634 2022-03-02

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

Phase 2 Completed

19 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT02484664 2022-01-20

COLA

Phase 2 Completed

12 enrolled 11 charts

Lymphangioleiomyomatosis

NCT00112502 2021-10-18

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

Phase 2 Completed

178 enrolled 23 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00033371 2020-09-29

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

Phase 2 Completed

205 enrolled 16 charts

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT00020878 2020-08-03

Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00062179 2020-08-03

Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02280694 2020-02-12

LDMchemoCRC

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00022399 2019-02-08

Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00068432 2018-10-31

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01220973 2018-06-08

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Phase 2 Completed

27 enrolled 6 charts

Prostatic Neoplasms

NCT00052611 2018-03-29

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

Phase 2 Completed

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

NCT01695226 2018-01-09

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00137852 2017-09-20

Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT00047281 2017-07-11

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00047294 2017-07-11

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Completed

Glioblastoma, Glioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00582660 2017-06-15

UAB0040

Phase 2 Completed

40 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

NCT00056082 2017-02-15

Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women

Phase 2 Completed

Breast Neoplasms

NCT00099047 2016-12-30

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Phase 2 Completed

23 enrolled 7 charts

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT00005878 2016-10-13

Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT00070486 2016-06-30

Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00931203 2016-05-04

Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal Cancer

Phase 2 Completed

Gastrointestinal

Locally Advanced Rectal Cancer

NCT00201773 2015-06-30

Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer

Phase 2 Completed

22 enrolled 9 charts

Breast Neoplasms

NCT00357500 2014-10-01

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Phase 2 Completed

101 enrolled 10 charts

CNSLymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms

NCT01678313 2014-07-15

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Phase 2 Completed

140 enrolled 10 charts

Prostatic Hyperplasia, Lower Urinary Tract Symptoms

NCT00698204 2014-06-05

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Phase 2 Completed

43 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT01756989 2014-05-08

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

Phase 2 Completed

Brainstem Glioma

NCT00006381 2013-12-19

Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00101335 2013-07-11

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Phase 2 Completed

Head & NeckOther neoplasm

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Leukoplakia, Oral, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Precancerous Conditions, Tongue Neoplasms

NCT00023621 2013-06-26

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Phase 2 Completed

Carcinoma, Basal Cell

NCT00043043 2013-06-19

Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00030407 2013-04-29

Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00030420 2013-04-29

Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00068653 2013-04-29

Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00258232 2013-04-08

Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00336960 2013-03-05

Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00014404 2013-01-16

Celecoxib in Treating Patients With Precancerous Lesions of the Mouth

Phase 2 Completed

Head and Neck Neoplasms, Mouth Neoplasms

NCT00466505 2012-12-19

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

Phase 2 Completed

17 enrolled 15 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00058006 2012-06-11

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Phase 2 Completed

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Salivary Gland Neoplasms

NCT00135018 2012-05-24

Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00520091 2012-05-18

Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00504660 2012-01-11

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

Phase 2 Completed

75 enrolled 8 charts

Brain Neoplasms, Glioblastoma

NCT00055978 2011-06-20

Celecoxib in Preventing Lung Cancer in Former Heavy Smokers

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01124435 2010-06-04

carbo-cox2

Phase 2 Completed

Ovarian Neoplasms

NCT00066716 2009-12-08

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00181532 2009-06-30

Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung